Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Buyout

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Dec 25, 2022 9:07pm

214 Views

Post# 35191763

RE:RE:RE:Buyout

UglyKidStock wrote: Shareholder Robbery under the distraction of Xmas. Stealing it for debt - cash with no stock option over hang and all of the good news on approvals coming in first half 2023. Without the options 'warrants owed to Red Oak the Enterprise value is quite low. These things were rapidly expiring already. What is Red Oaks angle ?

I agree it's highway robbery and a sellout by mgmt. NR does not mention co. had $31 million CAD in cash at Sept 30, making net debt only $75 million CAD. This means the buyout offer only values next year's ebitda at 4.165x using Bllom Burton's forecast of ebitda. If the multiple is raised to 5x the offer would need to be $2.94/sh. I'm voting no to this stink bid.

https://www.bloomburton.com/research/MRV20221116.pdf